nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Gemfibrozil—PPARA—atherosclerosis	0.09	0.817	CrCbGaD
Bupranolol—Clenbuterol—TNF—atherosclerosis	0.0201	0.183	CrCbGaD
Bupranolol—ADRB3—Signaling by GPCR—MMP3—atherosclerosis	0.00112	0.00125	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PRKCG—atherosclerosis	0.0011	0.00124	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.0011	0.00124	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CNR2—atherosclerosis	0.0011	0.00124	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00108	0.00121	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EDN1—atherosclerosis	0.00106	0.00119	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL5—atherosclerosis	0.00105	0.00118	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—AGT—atherosclerosis	0.00102	0.00115	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PRKCG—atherosclerosis	0.001	0.00113	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VWF—atherosclerosis	0.000997	0.00112	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—AGT—atherosclerosis	0.000997	0.00112	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOC3—atherosclerosis	0.000991	0.00111	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LDLR—atherosclerosis	0.000985	0.00111	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AGT—atherosclerosis	0.00097	0.00109	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL3—atherosclerosis	0.000966	0.00109	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR2—atherosclerosis	0.000962	0.00108	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000962	0.00108	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL3—atherosclerosis	0.000962	0.00108	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	0.000945	0.00106	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—F2—atherosclerosis	0.000942	0.00106	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000941	0.00106	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	0.000941	0.00106	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GHRL—atherosclerosis	0.000938	0.00105	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NCF1—atherosclerosis	0.000921	0.00104	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—F2—atherosclerosis	0.000921	0.00103	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	0.000917	0.00103	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOA4—atherosclerosis	0.000907	0.00102	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—F2—atherosclerosis	0.000896	0.00101	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOA4—atherosclerosis	0.000887	0.000997	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AGT—atherosclerosis	0.000881	0.00099	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	0.000874	0.000982	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	0.000874	0.000982	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000871	0.000979	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR2—atherosclerosis	0.00087	0.000977	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EDNRA—atherosclerosis	0.00087	0.000977	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CYBA—atherosclerosis	0.000866	0.000973	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000858	0.000964	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	0.000855	0.000961	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	0.000855	0.000961	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000852	0.000958	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	0.000852	0.000957	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PLAT—atherosclerosis	0.000848	0.000953	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PARP1—atherosclerosis	0.000848	0.000953	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GHRL—atherosclerosis	0.000848	0.000953	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	0.000839	0.000943	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	0.000836	0.000939	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	0.000833	0.000936	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	0.000823	0.000925	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	0.000821	0.000922	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000818	0.00092	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	0.000817	0.000919	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—F2—atherosclerosis	0.000814	0.000915	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000805	0.000905	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000801	0.0009	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	0.000781	0.000877	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000779	0.000875	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	0.000764	0.000858	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	0.000748	0.00084	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	0.000745	0.000837	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KNG1—atherosclerosis	0.000744	0.000836	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	0.000743	0.000835	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGTR1—atherosclerosis	0.00074	0.000831	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000731	0.000822	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	0.000729	0.000819	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000727	0.000817	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL2—atherosclerosis	0.000726	0.000815	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PLG—atherosclerosis	0.000721	0.00081	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	0.000714	0.000802	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CASR—atherosclerosis	0.000714	0.000802	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	0.0007	0.000787	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	0.000699	0.000785	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000699	0.000785	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	0.000694	0.00078	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	0.000688	0.000774	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.000685	0.00077	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SOCS3—atherosclerosis	0.000683	0.000767	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000679	0.000763	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.000673	0.000757	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	0.000664	0.000746	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	0.000663	0.000746	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	0.000662	0.000744	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP3—atherosclerosis	0.000659	0.000741	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF2—atherosclerosis	0.000656	0.000738	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000654	0.000735	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	0.000649	0.00073	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.000649	0.000729	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	0.000648	0.000728	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.00064	0.000719	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOB—atherosclerosis	0.000637	0.000716	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000632	0.00071	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	0.00063	0.000708	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EDN1—atherosclerosis	0.000627	0.000705	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	0.000625	0.000702	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL5—atherosclerosis	0.000622	0.000699	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	0.000616	0.000693	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	0.000612	0.000687	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LPL—atherosclerosis	0.000608	0.000684	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	0.000594	0.000668	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	0.000592	0.000665	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKCG—atherosclerosis	0.000592	0.000665	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	0.000588	0.000661	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	0.000584	0.000657	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.000581	0.000653	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	0.000579	0.00065	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SPP1—atherosclerosis	0.000576	0.000648	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	0.000576	0.000647	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	0.000575	0.000646	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—atherosclerosis	0.000574	0.000645	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	0.000572	0.000642	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	0.000571	0.000642	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	0.000563	0.000633	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	0.000558	0.000628	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	0.000547	0.000614	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	0.000535	0.000601	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PDGFB—atherosclerosis	0.000533	0.000599	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	0.000532	0.000598	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	0.000523	0.000588	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	0.000521	0.000585	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGT—atherosclerosis	0.00052	0.000585	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	0.000516	0.00058	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	0.000516	0.00058	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	0.000514	0.000578	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	0.000512	0.000575	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOE—atherosclerosis	0.00051	0.000573	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LEP—atherosclerosis	0.00051	0.000573	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000509	0.000572	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CAV1—atherosclerosis	0.000505	0.000568	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	0.000505	0.000568	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	0.000505	0.000568	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOA1—atherosclerosis	0.000504	0.000566	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	0.000503	0.000565	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	0.000503	0.000565	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	0.000503	0.000565	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	0.000503	0.000565	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000498	0.00056	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	0.000492	0.000553	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	0.000492	0.000553	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	0.000492	0.000553	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ESR1—atherosclerosis	0.000487	0.000547	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	0.000483	0.000543	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—F2—atherosclerosis	0.000481	0.00054	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	0.000473	0.000531	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000462	0.00052	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CG—atherosclerosis	0.00046	0.000517	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000452	0.000508	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	0.000442	0.000496	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK3—atherosclerosis	0.000441	0.000495	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	0.000439	0.000493	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—INS—atherosclerosis	0.000436	0.00049	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	0.000432	0.000485	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	0.000431	0.000484	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	0.000429	0.000483	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—atherosclerosis	0.000429	0.000482	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	0.000428	0.000481	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1—atherosclerosis	0.000421	0.000474	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	0.000421	0.000473	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	0.000418	0.00047	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	0.000405	0.000455	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SERPINE1—atherosclerosis	0.0004	0.00045	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	0.000396	0.000445	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	0.000391	0.00044	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	0.00039	0.000438	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	0.000383	0.00043	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOS3—atherosclerosis	0.000382	0.000429	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	0.000381	0.000428	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	0.000378	0.000425	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000375	0.000421	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	0.000372	0.000418	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	0.00037	0.000416	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	0.000369	0.000415	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000367	0.000412	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	0.000364	0.000409	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	0.000361	0.000406	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	0.000361	0.000406	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	0.000353	0.000397	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	0.000351	0.000395	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	0.000343	0.000386	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	0.000342	0.000384	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	0.00034	0.000383	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—atherosclerosis	0.000339	0.000381	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	0.000335	0.000376	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	0.000333	0.000374	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AKT1—atherosclerosis	0.000327	0.000368	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—atherosclerosis	0.000322	0.000362	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	0.000316	0.000356	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	0.00031	0.000348	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	0.000309	0.000347	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—atherosclerosis	0.000307	0.000344	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NFKB1—atherosclerosis	0.000303	0.000341	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	0.000303	0.00034	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	0.000303	0.00034	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	0.000302	0.00034	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	0.0003	0.000337	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	0.000299	0.000336	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK8—atherosclerosis	0.000298	0.000335	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AKT1—atherosclerosis	0.000297	0.000334	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	0.000296	0.000333	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	0.000296	0.000333	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	0.000293	0.00033	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	0.000293	0.000329	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	0.000289	0.000325	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—F2—atherosclerosis	0.000285	0.000321	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	0.000283	0.000318	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—F2—atherosclerosis	0.000279	0.000314	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—atherosclerosis	0.000275	0.000309	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	0.000273	0.000307	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STAT3—atherosclerosis	0.000273	0.000306	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	0.000267	0.0003	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	0.000262	0.000294	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	0.00026	0.000293	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—INS—atherosclerosis	0.000259	0.000291	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	0.000256	0.000288	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	0.000254	0.000286	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—INS—atherosclerosis	0.000253	0.000284	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	0.000253	0.000284	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	0.00025	0.000281	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	0.000249	0.00028	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	0.000245	0.000275	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	0.000238	0.000267	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	0.000232	0.000261	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	0.000227	0.000255	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	0.000222	0.000249	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	0.000201	0.000226	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	0.000197	0.000221	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	0.000194	0.000218	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	0.000191	0.000215	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—atherosclerosis	0.00019	0.000214	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	0.00019	0.000214	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	0.000187	0.00021	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	0.000182	0.000204	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	0.00018	0.000202	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	0.000178	0.0002	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	0.000177	0.000199	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	0.000176	0.000198	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	0.000176	0.000198	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT1—atherosclerosis	0.000176	0.000197	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	0.000173	0.000194	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	0.000173	0.000194	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	0.000163	0.000184	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	0.000162	0.000182	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	0.00016	0.00018	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	0.000158	0.000178	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	0.000155	0.000174	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	0.000151	0.00017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	0.00015	0.000168	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	0.000147	0.000165	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	0.000113	0.000127	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	0.000111	0.000124	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	0.000104	0.000117	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	0.000102	0.000115	CbGpPWpGaD
